Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy

Neurology India

Volumn 58, Issue 2, 2010, Pages 220-224

  Sharma, Praveen ^a   Sharma, Barjesh Chander ^a   Sarin, Shiv Kumar ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Critical flicker frequency; hepatic encephalopathy; psychometric tests

Indexed keywords

AMMONIA; LACTULOSE;

ADULT; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CRITICAL FLICKER FUSION; DAILY LIFE ACTIVITY; DIGIT SYMNBOL TEST; FEMALE; FIGURE CONNECTION TEST; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUMBER CONNECTION TEST; OBJECT ASSEMBLY TEST; PREVALENCE; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ADULT; EVENT-RELATED POTENTIALS, P300; FEMALE; FLICKER FUSION; HEPATIC ENCEPHALOPATHY; HUMANS; LACTULOSE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PSYCHOMETRICS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 77953758462     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.63797     Document Type: Article

References (24)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721
2. Amodio P, Del Piccolo F, Petteno E, Mapelli D, Angeli P, Iemmolo R, et al. Prevalence and prognostic value of quantified electroencephalogram Sharma, et al.: Abnormal psychometric and CFF after HE recovery (EEG) alterations in cirrhotic patients. J Hepatol 2001;35:37-45.
3. Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar- Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001;96:2718-2723
4. Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol 2000;32:748-753
5. Saxena N, Bhatia M, Joshi YK, Garg PK, Garg PK, Tandon RK. Auditory P300 event-related potentials and number connection test for evaluation of sub- clinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study. J Gastroenterol Hepatol 2001;16:322-327
6. Dhiman RK, Saraswat VA, Verma M, Naik SR. Figure connection tests:A universal test for assessment of mental state. J Gastroenterol Hepatol 1995;10:14-23.
7. Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy J Hepatol 2007;47:67-73.
8. Romer Gómez M, Córdoba J, Jover R, del Olmo JA, Ramírez M, Rey R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007;45:879-885
9. Jalan R, Shawcross D, Davies N. The molecular pathogenesis of hepatic encephalopathy. Int J Biochem Cell Biol 2003;35:1175-1181
10. Lockwood AH, Yap EW, Wong WH. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991;11:337-341
11. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001;16:531-535
12. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000;95:2029-2034
13. Bajaj JS, Etemadian A, Hafeezullah M, Saeian K. Testing for minimal hepatic encephalopathy in the United States: An AASLD survey. Hepatology 2007;45:833-834
14. Ramalingaswamy P. Manual of Indian Adaptation of WAIS Performance Scale. Delhi: Manasayan; 1974. p. 2-29.
15. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977;72:573-583
16. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001;16:37-41.
17. SchomerusM, Hamster W, Blunck H, Reinhard U, Mayer K, Dölle W. Latent portosystemic encephalopathy. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981;26:622-630
18. Groeneweg M, Quero JC, De Bruijin I, Hartmann IJ, Essink-bot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45-49
19. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005;42:S45-53.
20. Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol 2009;28:5-16.
21. Stewart CA, Smith GE Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol 2007;4:677-685
22. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002;35:357-366
23. Sharma BC, Sharma P, Agrawal A, Sarin SK. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 2009;137:885-891
24. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007;45:549-559